张开玲,张文伟,臧传善.Ck19、Galectin-3及HBME-1在甲状腺乳头状癌中的表达及临床意义[J].肿瘤学杂志,2017,23(4):262-267. |
Ck19、Galectin-3及HBME-1在甲状腺乳头状癌中的表达及临床意义 |
Expressions of CK19,Gal-3 and HBME-1 in Thyroid Papillary Carcinoma |
投稿时间:2016-12-02 |
DOI:10.11735/j.issn.1671-170X.2017.04.B002 |
|
|
中文关键词: CK19 Galectin-3 HBME-1 甲状腺肿瘤 乳头状癌 免疫组织化学 |
英文关键词:CK19 Galectin-3 HBME-1 thyroid neoplasms papillary carcinoma immunohistochemistry |
基金项目: |
|
摘要点击次数: 1846 |
全文下载次数: 605 |
中文摘要: |
摘 要:[目的] 探讨细胞角蛋白19(CK19)、半乳糖凝集素(Galectin-3)、间皮瘤抗原-1 (HBME-1)在甲状腺乳头状癌中的表达及临床意义。[方法] 采用免疫组织化学方法检测60例甲状腺良恶性病变(甲状腺乳头状癌40例,癌旁甲状腺组织40例,结节性甲状腺肿20例)中CK19、Galectin-3和HBME-1的表达。[结果] CK19在甲状腺乳头状癌组织、癌旁甲状腺组织及结节性甲状腺肿组织中表达的阳性率分别为95.0%(38/40)、32.5%(13/40)和15.0%(3/20),Galectin-3表达的阳性率分别为92.5%(37/40)、5.0%(2/40)和20.0%(4/20),HBME-1的表达的阳性率分别为92.5%(37/40)、0和5.0%(1/20);三种抗体在甲状腺乳头状癌和癌旁甲状腺组织、结节性甲状腺肿组织的阳性表达率差异均具有统计学意义(χ2=45.115,P<0.001;χ2=66.646,P<0.001;χ2=84.048,P<0.001)。[结论] CK19、Galectin-3和HBME-1在甲状腺乳头状癌组织中的表达明显高于癌旁组织和良性病变组织,三种标志物联合检测将进一步提高甲状腺乳头状癌的诊断准确性。 |
英文摘要: |
Abstract:[Objective] To investigate the expressions of cytokeratin 19(CK19),Galectin-3(Gal-3) and HBME-1 in papillary thyroid carcinoma. [Methods] The expressions of CK19,Gal-3 and HBME-1 in 40 cases of thyroid papillary carcinoma and corresponding adjacent thyroid tissue,and 20 cases of nodular goiter were detected by immunohistochemistry. [Results] The positive rate of CK19 expression in papillary thyroid carcinoma,pericancerous thyroid tissues and nodular goiter was 95.0%(38/40),32.5%(13/40) and 15.0%(3/20) respectively. The positive rates of Gal-3 and HBME-1 expression were 92.5%(37/40),5.0%(2/40),20.0%(4/20) and 92.5%(37/40) ,0%(0/40),5.0%(1/20),respectively. The positive expression rates of these three proteins in papillary thyroid carcinoma,thyroid cancer adjacent tissues and nodular goiter were significantly different(χ2=45.115,P<0.001;χ2=66.646,P<0.001;χ2=84.048,P<0.001,respectively). [Conclusion] The expression rates of CK19,Gal-3 and HBME-1 in papillary thyroid carcinoma are significantly higher than those in paracancerous tissues and benign lesions. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |